Contact

All Stories

  1. Worldwide Radiation Dose in Coronary Artery Disease Diagnostic Imaging

    Article • JAMA, February 2026, American Medical Association (AMA)

    Professor marija B Vavlukis

  2. The Paradox of SMURF-less Outcomes and its Implication for Diabetes

    Article • European Heart Journal - Quality of Care and Clinical Outcomes, January 2026, Oxford University Press (OUP)

    Dr Edina Cenko, Professor marija B Vavlukis

  3. Sex and gender differences in coronary pathophysiology and ischaemic heart disease

    Article • European Heart Journal, January 2026, Oxford University Press (OUP)

    Professor marija B Vavlukis

  4. Diet and sex inequities in ischemic heart disease mortality across Europe: findings from the global burden of disease study

    Article • Cardiovascular Research, November 2025, Oxford University Press (OUP)

    Professor marija B Vavlukis

  5. Impact of age and sex on the efficacy of early invasive strategy in patients presenting in stable conditions after acute coronary syndromes

    Article • European Heart Journal, November 2025, Oxford University Press (OUP)

    Professor marija B Vavlukis

  6. Changing clinical perspectives on sex and healthcare disparities in ischaemic heart disease

    Article • The Lancet Regional Health - Europe, September 2025, Elsevier

    Dr Edina Cenko, Professor marija B Vavlukis

  7. Age and sex differences in the efficacy of early invasive strategy for non-ST-elevation acute coronary syndrome: A comparative analysis in stable patients

    Article • American Journal of Preventive Cardiology, June 2025, Elsevier

    Professor marija B Vavlukis

  8. AGE AND SEX DIFFERENCES IN THE EFFICACY OF EARLY INVASIVE STRATEGY FOR NON-STELEVATION ACUTE CORONARY SYNDROME: A COMPARATIVE ANALYSIS IN STABLE PATIENTS

    Article • Journal of the American College of Cardiology, April 2025, Elsevier

    Professor marija B Vavlukis

  9. 225 Basic/Advanced Life Support Training for Healthcare Professionals in the European Union

    Article • Resuscitation, November 2024, Elsevier

    Professor marija B Vavlukis

  10. Biochemical variables as predictors of in-hospital mortality in patients with acute coronary syndrome

    Article • European Heart Journal, October 2024, Oxford University Press (OUP)

    Professor marija B Vavlukis

  11. Early coronary revascularization among stable patients with non-ST-segment elevation acute coronary syndromes: the role of diabetes and age

    Article • European Heart Journal, October 2024, Oxford University Press (OUP)

    Professor marija B Vavlukis

  12. Unraveling the paradox: the impact of one or more traditional risk factors on short-term mortality following acute coronary syndromes.

    Article • European Heart Journal, October 2024, Oxford University Press (OUP)

    Professor marija B Vavlukis

  13. Early coronary revascularization among ‘stable’ patients with non-ST-segment elevation acute coronary syndromes: the role of diabetes and age

    Article • Cardiovascular Research, August 2024, Oxford University Press (OUP)

    Professor marija B Vavlukis, Dr Edina Cenko

  14. Editorial: Insights in intensive care cardiovascular medicine: 2022

    Article • Frontiers in Cardiovascular Medicine, August 2024, Frontiers

    Professor marija B Vavlukis

  15. The European Society of Cardiology Working Group on Coronary Pathophysiology and Microcirculation

    Article • Cardiovascular Research, July 2024, Oxford University Press (OUP)

    Professor marija B Vavlukis, Dr Edina Cenko

  16. Coronary revascularization and sex differences in cardiovascular mortality after myocardial infarction in 12 high and middle-income European countries

    Article • European Heart Journal - Quality of Care and Clinical Outcomes, May 2024, Oxford University Press (OUP)

    Professor marija B Vavlukis, Dr Edina Cenko

  17. TRADITIONAL RISK FACTORS AND PREMATURE ACUTE CORONARY SYNDROMES IN SOUTH EASTERN EUROPE

    Article • Journal of the American College of Cardiology, April 2024, Elsevier

    Professor marija B Vavlukis

  18. Acute kidney injury in patients with acute coronary syndrome - risk profile

    Article • European Heart Journal Acute Cardiovascular Care, April 2024, Oxford University Press (OUP)

    Professor marija B Vavlukis

  19. Left ventricular systolic function in patients with acute coronary syndrome-risk profile

    Article • European Heart Journal Acute Cardiovascular Care, April 2024, Oxford University Press (OUP)

    Professor marija B Vavlukis

  20. The role of pre-existing renal dysfunction on in-hospital morbidity and mortality in patients with acute coronary syndrome

    Article • European Heart Journal Acute Cardiovascular Care, April 2024, Oxford University Press (OUP)

    Professor marija B Vavlukis

  21. Traditional risk factors and premature acute coronary syndromes in South Eastern Europe: a multinational cohort study

    Article • The Lancet Regional Health - Europe, January 2024, Elsevier

    Professor marija B Vavlukis, Dr Edina Cenko

  22. Are diabetes mellitus and lipoprotein(a) independently or causally associated with an increased cardiovascular risk?

    Article • The Anatolian Journal of Cardiology, January 2024, Kare Publishing

    Professor marija B Vavlukis

  23. Abstract 18529: Early Coronary Revascularization Among "Stable" Patients With Non-ST-Segment Elevation Acute Coronary Syndromes: The Role of Diabetes and Age

    Article • Circulation, November 2023, Wolters Kluwer Health

    Professor marija B Vavlukis

  24. Abstract 16665: Traditional Risk Factors and Acute Coronary Syndrome Free Survival

    Article • Circulation, November 2023, Wolters Kluwer Health

    Professor marija B Vavlukis

  25. Ischemic burden and cardiovascular mortality in 12 middle- and high-income European countries

    Article • European Heart Journal, November 2023, Oxford University Press (OUP)

    Professor marija B Vavlukis

  26. Age and Gender Impact on Heart Rate Variability towards Noninvasive Glucose Measurement

    Article • Sensors, October 2023, MDPI AG

    Professor marija B Vavlukis

  27. Rosuvastatin effects on the HDL proteome in hyperlipidemic patients

    Article • Acta Pharmaceutica, September 2023, De Gruyter

    Professor marija B Vavlukis, Dr Katarina Davalieva

  28. Perivascular adipose tissue as a source of therapeutic targets and clinical biomarkers

    Article • European Heart Journal, August 2023, Oxford University Press (OUP)

    Professor marija B Vavlukis

  29. Correction to: Relationship between Azithromycin and Cardiovascular Outcomes in Unvaccinated Patients With COVID‐19 and Preexisting Cardiovascular Disease

    Article • Journal of the American Heart Association, August 2023, Wolters Kluwer Health

    Professor marija B Vavlukis

  30. Relationship Between Azithromycin and Cardiovascular Outcomes in Unvaccinated Patients With COVID‐19 and Preexisting Cardiovascular Disease

    Article • Journal of the American Heart Association, July 2023, Wolters Kluwer Health

    Professor marija B Vavlukis, Dr Edina Cenko

  31. Sex Differences in Heart Failure Following Acute Coronary Syndromes

    Article • JACC Advances, May 2023, Elsevier

    Professor marija B Vavlukis, Dr Edina Cenko

  32. SEX DIFFERENCES AND DISPARITIES IN CARDIOVASCULAR COMPLICATIONS AND INTENSIVE CARE UNIT ADMISSION ASSOCIATED WITH COVID-19

    Article • Journal of the American College of Cardiology, March 2023, Elsevier

    Professor marija B Vavlukis

  33. Presentation, care, and outcomes of patients with NSTEMI according to World Bank country income classification: the ACVC-EAPCI EORP NSTEMI Registry of the European Society of Cardiology

    Article • European Heart Journal - Quality of Care and Clinical Outcomes, February 2023, Oxford University Press (OUP)

    Professor Erkin Mirrakhimov, Prof HECTOR BUENO, Professor marija B Vavlukis, Asoc Prof MD PhD FESC Oliver Kalpak, Dr Juan C Garcia-Rubira

  34. Sex differences and disparities in cardiovascular outcomes of COVID-19

    Article • Cardiovascular Research, January 2023, Oxford University Press (OUP)

    Dr Edina Cenko, Professor marija B Vavlukis

  35. Evaluation of ongoing stability data for Zolpidem film coated tablets using statistical methods for trending analysis

    Article • Macedonian Pharmaceutical Bulletin, December 2022, Macedonian Pharmaceutical Association

    Professor marija B Vavlukis

  36. Abstract 11122: Sex Differences and Disparities in Cardiovascular Outcomes of Covid-19

    Article • Circulation, November 2022, Wolters Kluwer Health

    Professor marija B Vavlukis

  37. Cohort Profile: The ESC EURObservational Research Programme Non-ST-segment elevation myocardial infraction (NSTEMI) Registry

    Article • European Heart Journal - Quality of Care and Clinical Outcomes, October 2022, Oxford University Press (OUP)

    Prof HECTOR BUENO, Professor Erkin Mirrakhimov, Professor marija B Vavlukis, Asoc Prof MD PhD FESC Oliver Kalpak, Dr Juan C Garcia-Rubira

  38. COVID-19 and acute heart failure among patients with cancer

    Article • European Heart Journal, October 2022, Oxford University Press (OUP)

    Professor marija B Vavlukis

  39. Prevalence of standard modifiable cardiovascular risk factors in patients with ST segment elevation myocardial infarction and its relation with outcomes

    Article • European Heart Journal, October 2022, Oxford University Press (OUP)

    Professor marija B Vavlukis

  40. Prognostic value of brain natriuretic peptide in COVID-19 with or without acute heart failure

    Article • European Heart Journal, October 2022, Oxford University Press (OUP)

    Professor marija B Vavlukis

  41. Relation between sex and mortality after myocardial infarction in high-income and middle-income European countries

    Article • European Heart Journal, October 2022, Oxford University Press (OUP)

    Professor marija B Vavlukis

  42. Paraoxonase 1 gene polymorphisms in lipid oxidation and atherosclerosis development

    Article • Frontiers in Genetics, September 2022, Frontiers

    Professor marija B Vavlukis

  43. Worldwide Disparities in Recovery of Cardiac Testing 1 Year Into COVID-19

    Article • Journal of the American College of Cardiology, May 2022, Elsevier

    Dr Ahmad Ozair, Professor marija B Vavlukis, Associate Professor Dr Noor Khairiah A. Karim

  44. Mechanisms, therapeutic implications, and methodological challenges of gut microbiota and cardiovascular diseases: a position paper by the ESC Working Group on Coronary Pathophysiology and Microcirculation

    Article • Cardiovascular Research, April 2022, Oxford University Press (OUP)

    Dr Edina Cenko, Professor marija B Vavlukis

  45. Antioxidative Effects of Rosuvastatin in Low-to-Moderate Cardiovascular Risk Subjects

    Article • March 2022, De Gruyter

    Professor marija B Vavlukis

  46. SEX DIFFERENCES IN MORTALITY AFTER MYOCARDIAL INFARCTION IN HIGH-INCOME AND MIDDLE-INCOME EUROPEAN COUNTRIES.

    Article • Journal of the American College of Cardiology, March 2022, Elsevier

    Professor marija B Vavlukis

  47. Incremental Value of Cardiac Biomarkers in Mid-term Prognosis of Patients with Acute Coronary Syndrome

    Article • Open Access Macedonian Journal of Medical Sciences, February 2022, Macedonian Journal of Medical Science

    Professor marija B Vavlukis

  48. Comparing Time and Frequency Domain Heart Rate Variability for Deep Learning-Based Glucose Detection

    Article • January 2022, Springer Science + Business Media

    Professor marija B Vavlukis

  49. THE EFFECT OF METHYLPREDNISOLONE VERSUS DEXAMETHASONE IN INCREASING THE DIABETOGENIC EFFECT OF SARS-CoV-2 INFECTION AND THE DEVELOPMENT OF A NEW-ONSET DIABETES MELLITUS

    Article • Journal of Morphological Sciences, January 2022, Revija za socijalna politika, Faculty of Philosophy, Ss. Cyril and Methodius Skopje

    Professor marija B Vavlukis

  50. Anti-inflammatory and immunomodulatory effects of rosuvastatin in patients with low-to-moderate cardiovascular risk

    Article • Acta Pharmaceutica, December 2021, De Gruyter

    Professor marija B Vavlukis

  51. Left Ventricular Aneurysm with Recurrent Ventricular Tachycardia

    Article • South East European Journal of Cardiology, December 2021, Macedonian Journal of Medical Science

    Professor marija B Vavlukis

  52. Abstract 13310: Early Percutaneous Coronary Intervention: Risks and Outcomes in Patients With Cancer

    Article • Circulation, November 2021, Wolters Kluwer Health

    Professor marija B Vavlukis

  53. Acute heart failure: a mechanism underscoring sex differences in outcomes following acute coronary syndromes

    Article • European Heart Journal, October 2021, Oxford University Press (OUP)

    Professor marija B Vavlukis

  54. Is early percutaneous coronary intervention safe in patients ACS and cancer?

    Article • European Heart Journal, October 2021, Oxford University Press (OUP)

    Professor marija B Vavlukis

  55. Distribution Analysis of Long-Term Heart Rate Variability Versus Blood Glucose

    Article • September 2021, Institute of Electrical & Electronics Engineers (IEEE)

    Professor marija B Vavlukis

  56. Developing A Deep Learning Solution to Estimate Instantaneous Glucose Level from Heart Rate Variability

    Article • September 2021, Institute of Electrical & Electronics Engineers (IEEE)

    Professor marija B Vavlukis

  57. Myocardial Infarction in Systemic Lupus Erythematosus – the Sex-Specific Risk Profile

    Article • Current Pharmaceutical Design, September 2021, Bentham Science Publishers

    Professor marija B Vavlukis

  58. Cardiovascular disease and COVID-19: a consensus paper from the ESC Working Group on Coronary Pathophysiology & Microcirculation, ESC Working Group on Thrombosis and the Association for Acute CardioVascular Care (ACVC), in collaboration with the Eu...

    Article • Cardiovascular Research, September 2021, Oxford University Press (OUP)

    Dr Edina Cenko, Professor marija B Vavlukis

  59. Impact of COVID-19 on Cardiovascular Testing in the United States Versus the Rest of the World

    Article • JACC Cardiovascular Imaging, September 2021, Elsevier

    Dr Nobuo Tomizawa, Dr Ahmad Ozair, Professor marija B Vavlukis, Associate Professor Dr Noor Khairiah A. Karim

  60. Impact of COVID-19 Pandemic on Cardiovascular Testing in Asia

    Article • JACC Asia, September 2021, Elsevier

    Dr Ahmad Ozair, Professor marija B Vavlukis, Associate Professor Dr Noor Khairiah A. Karim

  61. Impact of SARS-CoV-2 positivity on clinical outcome among STEMI patients undergoing mechanical reperfusion: Insights from the ISACS STEMI COVID 19 registry

    Article • Atherosclerosis, September 2021, Elsevier

    Professor marija B Vavlukis

  62. Functional and structural adaptations of the coronary macro- and microvasculature to regular aerobic exercise by activation of physiological, cellular, and molecular mechanisms: ESC Working Group on Coronary Pathophysiology and Microcirculation positio...

    Article • Cardiovascular Research, August 2021, Oxford University Press (OUP)

    Dr Edina Cenko, Professor marija B Vavlukis

  63. Impact of COVID-19 on the imaging diagnosis of cardiac disease in Europe

    Article • Open Heart, August 2021, BMJ

    Dr Ahmad Ozair, Professor marija B Vavlukis, Associate Professor Dr Noor Khairiah A. Karim

  64. International Prospective Registry of Acute Coronary Syndromes in Patients With COVID-19

    Article • Journal of the American College of Cardiology, May 2021, Elsevier

    Professor marija B Vavlukis

  65. SEX DIFFERENCES IN HEART FAILURE FOLLOWING ACUTE CORONARY SYNDROMES

    Article • Journal of the American College of Cardiology, May 2021, Elsevier

    Professor marija B Vavlukis

  66. STATINS AND SEVERITY OF CLINICAL MANIFESTATIONS AMONG WOMEN AND MEN WITH INCIDENT CORONARY HEART DISEASE

    Article • Journal of the American College of Cardiology, May 2021, Elsevier

    Professor marija B Vavlukis

  67. Comparison of 24 h ECG Holter Monitoring with Real-time Long-term ECG Monitoring System using ECGalert Software and Savvy Single-Lead Patch

    Article • Open Access Macedonian Journal of Medical Sciences, January 2021, Macedonian Journal of Medical Science

    Professor marija B Vavlukis

  68. International Impact of COVID-19 on the Diagnosis of Heart Disease

    Article • Journal of the American College of Cardiology, January 2021, Elsevier

    Dr Ahmad Ozair, Professor marija B Vavlukis, Associate Professor Dr Noor Khairiah A. Karim

  69. GENDER DIFFERENCES AND PREDICTORS OF INCRASED CORONARY CALCIUM SCORE AND MYOCARDIAL ISCHEMIA IN DIABETES TYPE 2 PATIENTS

    Article • Journal of Morphological Sciences, January 2021, Revija za socijalna politika, Faculty of Philosophy, Ss. Cyril and Methodius Skopje

    Professor marija B Vavlukis

  70. Impact of COVID-19 pandemic and diabetes on mechanical reperfusion in patients with STEMI: insights from the ISACS STEMI COVID 19 Registry

    Article • Cardiovascular Diabetology, December 2020, Springer Science + Business Media

    Professor marija B Vavlukis

  71. Correlating Short-Term Heart Rate Variability and Instantaneous Blood Glucose Measurements

    Article • November 2020, Institute of Electrical & Electronics Engineers (IEEE)

    Professor marija B Vavlukis

  72. Heart Rate Variability of 30-minute ECG Measurements and Correlation to Glucose Levels

    Article • November 2020, Institute of Electrical & Electronics Engineers (IEEE)

    Professor marija B Vavlukis

  73. Abstract 13648: Sex Differences in Modifiable Risk Factors and Severity of Coronary Artery Disease

    Article • Circulation, November 2020, Wolters Kluwer Health

    Professor marija B Vavlukis

  74. Added Value of Modified Anderson–Wilkins Acuteness Score in Prognostication of Patients with Acute Myocardial Infarction

    Article • Open Access Macedonian Journal of Medical Sciences, November 2020, Macedonian Journal of Medical Science

    Professor marija B Vavlukis

  75. Novel Inflammatory Biomarkers as Additional Value to Traditional Risk-factors in Cardiovascular Risk Stratification

    Article • Open Access Macedonian Journal of Medical Sciences, November 2020, Macedonian Journal of Medical Science

    Professor marija B Vavlukis

  76. Impact of COVID-19 Pandemic on Mechanical Reperfusion for Patients With STEMI

    Article • Journal of the American College of Cardiology, November 2020, Elsevier

    Professor marija B Vavlukis

  77. Risk factors, revascularization therapies and cardiovascular mortality in countries with middle and low public health expenditure

    Article • European Heart Journal, November 2020, Oxford University Press (OUP)

    Professor marija B Vavlukis

  78. Is there a place for rosuvastatin in the Lp(a) management?

    Article • Macedonian Pharmaceutical Bulletin, October 2020, Macedonian Pharmaceutical Association

    Professor marija B Vavlukis

  79. Sex Differences in Modifiable Risk Factors and Severity of Coronary Artery Disease

    Article • Journal of the American Heart Association, October 2020, Wolters Kluwer Health

    Professor marija B Vavlukis

  80. Aspirin for primary prevention of ST segment elevation myocardial infarction in persons with diabetes and multiple risk factors

    Article • EClinicalMedicine, October 2020, Elsevier

    Professor marija B Vavlukis

  81. ESC Working Group on Coronary Pathophysiology and Microcirculation position paper on ‘coronary microvascular dysfunction in cardiovascular disease’

    Article • Cardiovascular Research, February 2020, Oxford University Press (OUP)

    Dr Edina Cenko, Professor marija B Vavlukis

  82. Organization of intensive cardiac care units in Europe: Results of a multinational survey

    Article • European Heart Journal Acute Cardiovascular Care, January 2020, SAGE Publications

    Prof Marc Claeys, Professor marija B Vavlukis, Dr Mohamed H Laimoud

  83. Correlating Glucose Regulation with Lipid Profile

    Article • January 2020, Springer Science + Business Media

    Professor marija B Vavlukis

  84. Sex-Related Differences in Heart Failure After ST-Segment Elevation Myocardial Infarction

    Article • Journal of the American College of Cardiology, November 2019, Elsevier

    Professor marija B Vavlukis

  85. P6419Machine learning in critical care: the role of diabetes and age in acute coronary syndromes

    Article • European Heart Journal, October 2019, Oxford University Press (OUP)

    Professor marija B Vavlukis

  86. P3844Percutaneous coronary intervention in the age of frailty

    Article • European Heart Journal, October 2019, Oxford University Press (OUP)

    Professor marija B Vavlukis

  87. 2018 ESC Guidelines for the diagnosis and management of syncope

    Article • Russian Journal of Cardiology, August 2019, Silicea - Poligraf, LLC

    Professor marija B Vavlukis

  88. 2018 ESC/ESH Guidelines for the Management of Arterial Hypertension

    Article • June 2019, Taylor & Francis

    Professor marija B Vavlukis

  89. “DE NOVO” HEART FAILURE: A MECHANISM UNDERSCORING SEX DIFFERENCES IN OUTCOMES AFTER ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION

    Article • Journal of the American College of Cardiology, March 2019, Elsevier

    Professor marija B Vavlukis

  90. 2018 ESC/ESH Guidelines for the management of arterial hypertension

    Article • Kardiologia Polska, February 2019, Polskie Towarzystwo Kardiologiczne

    Prof HECTOR BUENO, Professor marija B Vavlukis, Salim Benkhedda, Professor Yuriy M. Sirenko

  91. Sex‐Specific Treatment Effects After Primary Percutaneous Intervention: A Study on Coronary Blood Flow and Delay to Hospital Presentation

    Article • Journal of the American Heart Association, February 2019, Wolters Kluwer Health

    Professor marija B Vavlukis

  92. 2018 ESC/ESH Guidelines for the management of arterial hypertension

    Article • Revista Española de Cardiología, February 2019, Elsevier

    Professor marija B Vavlukis

  93. When statin alone or in combination with ezetimibe are not еnough.

    Article • January 2019, IntechOpen

    Professor marija B Vavlukis

  94. Myocardial Perfusion Abnormalities in Young and Premenopausal Women with Systemic Lupus Erythematosus, Detected with 99MTC MIBI Myocardial Perfusion Scintigraphy – Prevalence and Correlation with Proatherogenic Factors

    Article • PRILOZI, December 2018, De Gruyter

    Professor marija B Vavlukis

  95. 2018 ESC/ESH Guidelines for the management of arterial hypertension

    Article • European Heart Journal, August 2018, Oxford University Press (OUP)

    Professor marija B Vavlukis, Prof HECTOR BUENO, Professor John GF Cleland, Salim Benkhedda

  96. 2018 ESC Guidelines for the diagnosis and management of syncope

    Article • Kardiologia Polska, August 2018, Polskie Towarzystwo Kardiologiczne

    Professor marija B Vavlukis

  97. P580Sex difference in the impact of delay to reperfusion on coronary blood flow and outcomes in ST-segment elevation myocardial infarction

    Article • European Heart Journal, August 2018, Oxford University Press (OUP)

    Asoc Prof MD PhD FESC Oliver Kalpak, Professor marija B Vavlukis

  98. Adding ezetimibe to statin therapy: latest evidence and clinical implications

    Article • Drugs in Context, July 2018, BioExcel

    Professor marija B Vavlukis

  99. The Impact of Glyco-Metabolic Status in Patients Treated for Acute Coronary Syndrome

    Article • PRILOZI, July 2018, De Gruyter

    Professor marija B Vavlukis

  100. Perfusión tejido-músculo evaluada mediante protocolo de un día de gammagrafía reposo-dipiramidol con 99m Tc-MIBI en pacientes no diabéticos y diabéticos

    Article • Revista Española de Medicina Nuclear e Imagen Molecular, May 2018, Elsevier

    Professor marija B Vavlukis

  101. Tissue-muscle perfusion assessed by one day 99m Tc-MIBI rest-dipyridamol scintigraphy in non-diabetic and diabetic patients

    Article • Revista Española de Medicina Nuclear e Imagen Molecular (English Edition), May 2018, Elsevier

    Professor marija B Vavlukis

  102. Effects of treatment with Statine on Dislipidemia in patients with diabetes.

    Article • Current Pharmaceutical Design, April 2018, Bentham Science Publishers

    Professor marija B Vavlukis

  103. 2018 ESC Guidelines for the diagnosis and management of syncope

    Article • European Heart Journal, March 2018, Oxford University Press (OUP)

    Professor Erkin Mirrakhimov, Professor marija B Vavlukis, Prof HECTOR BUENO, Dr Ayan Abdrakhmanov

  104. IMPACT OF THE AGE OF FRAILTY ON OUTCOMES AFTER PERCUTANEOUS CORONARY INTERVENTION IN ACUTE CORONARY SYNDROMES

    Article • Journal of the American College of Cardiology, March 2018, Elsevier

    Professor marija B Vavlukis, Asoc Prof MD PhD FESC Oliver Kalpak

  105. Secondary Thromboprophylaxis in Hereditary Thrombophilia

    Article • Cardiology and Angiology An International Journal, February 2018, Sciencedomain International

    Professor marija B Vavlukis

  106. Machine Learning in Critical Care: The Role of Diabetes and Age in Acute Coronary Syndromes

    Article • SSRN Electronic Journal, January 2018, Elsevier

    Professor marija B Vavlukis

  107. Acute Coronary Syndrome: The Risk to Young Women

    Article • Journal of the American Heart Association, December 2017, Wolters Kluwer Health

    Professor Lina Badimon, Dr Edina Cenko, Professor Raffaele Bugiardini, Professor marija B Vavlukis, Asoc Prof MD PhD FESC Oliver Kalpak

  108. P4652Myocardial infarction: process of care measures in eastern Europe: insights for complementary metrics

    Article • European Heart Journal, August 2017, Oxford University Press (OUP)

    Asoc Prof MD PhD FESC Oliver Kalpak, Professor marija B Vavlukis

  109. Influence of ABCB1 C3435T Genotype on Clinical Cardiovascular Outcomes in Coronary Artery Disease Patients on Clopidogrel Treatment

    Article • MOJ Drug Design Development & Therapy, May 2017, MedCrave Group LLC

    Professor marija B Vavlukis

  110. Can rivaroxaban be a drug of choice for treating heparin-induced thrombocytopenia in a patient with pulmonary thromboembolism?

    Article • Anadolu Kardiyoloji Dergisi/The Anatolian Journal of Cardiology, January 2017, Kare Publishing

    Professor marija B Vavlukis

  111. Effects of Rosuvastatin Versus Atorvastatin, Alone or in Combination, on Lipoprotein (a)

    Article • Annals of Pharmacotherapy, May 2016, SAGE Publications

    Professor marija B Vavlukis

  112. Comparison of Early Versus Delayed Oral β Blockers in Acute Coronary Syndromes and Effect on Outcomes

    Article • The American Journal of Cardiology, March 2016, Elsevier

    Professor marija B Vavlukis, Dr Edina Cenko, Professor Raffaele Bugiardini, Asoc Prof MD PhD FESC Oliver Kalpak

  113. Are diabetes mellitus and lipoprotein(a) independently or causally associated with an increased cardiovascular risk?

    Article • Anadolu Kardiyoloji Dergisi/The Anatolian Journal of Cardiology, January 2016, Kare Publishing

    Professor marija B Vavlukis

  114. Diffuse Arterial Thrombosis as a First Manifestation of Occult Malignancy

    Article • Case Reports in Medicine, January 2016, Hindawi Publishing Corporation

    Professor marija B Vavlukis

  115. Antiphospholipid Syndrome - A Case Report of Pulmonary Thromboembolism, Followed with Acute Myocardial Infarction in Patient with Systemic Sclerosis

    Article • Open Access Macedonian Journal of Medical Sciences, November 2015, Macedonian Journal of Medical Science

    Professor marija B Vavlukis

  116. Effects of rosuvastatin versus atorvastatin alone or in combination, on lipoprotein (a): a single center study.

    Article • Cardiologia Croatica, October 2015, Medical Publishing, d.o.o.

    Professor marija B Vavlukis

  117. Newly Diagnosed Diabetes and Stress Glycaemia and Its’ Association with Acute Coronary Syndrome

    Article • Open Access Macedonian Journal of Medical Sciences, September 2015, Macedonian Journal of Medical Science

    Professor marija B Vavlukis

  118. Poster Session 3: Tuesday 5 May 2015, 08:30-12:30 * Room: Poster Area

    Article • European Heart Journal - Cardiovascular Imaging, May 2015, European Society of Cardiology

    Professor Alexander E Berezin, Professor marija B Vavlukis

  119. Dual antiplatelet therapy duration after coronary stenting in clinical practice: results of an EAPCI survey

    Article • EuroIntervention, May 2015, Europa Digital & Publishing

    Dr Rafael Vidal-Perez, Dr Saurabh Kumar Gupta, Professor marija B Vavlukis

  120. SEX-RELATED DIFFERENCES IN ACUTE CORONARY CARE AMONG PATIENTS WITH MYOCARDIAL INFARCTION: THE ROLE OF PRE-HOSPITAL DELAY

    Article • Journal of the American College of Cardiology, March 2015, Elsevier

    Professor marija B Vavlukis, Dr Edina Cenko, Professor Raffaele Bugiardini, Asoc Prof MD PhD FESC Oliver Kalpak

  121. Frequencies of Single-Nucleotide Polymorphisms and Haplotypes of the SLCO1B1 Gene in Selected Populations of the Western Balkans

    Article • Balkan Journal of Medical Genetics, January 2015, De Gruyter

    Professor marija B Vavlukis, Ms Kristina Mladenovska

  122. 2014 ESC/ESA Guidelines on non-cardiac surgery

    Article • European Journal of Anaesthesiology, October 2014, Wolters Kluwer Health

    Prof HECTOR BUENO, Professor Erkin Mirrakhimov, Professor marija B Vavlukis

  123. Bergamo, Marija

    Article • September 2014, Oxford University Press (OUP)

    Professor marija B Vavlukis

  124. 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management

    Article • European Heart Journal, August 2014, European Society of Cardiology

    Prof HECTOR BUENO, Professor Erkin Mirrakhimov, Professor marija B Vavlukis

  125. Rhabdomyolysis and Cardiomyopathy in a 20-Year-Old Patient with CPT II Deficiency

    Article • Case Reports in Genetics, January 2014, Hindawi Publishing Corporation

    Professor marija B Vavlukis

  126. Cardiovascular Disease

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 2014, De Gruyter

    Professor marija B Vavlukis

  127. Myocardial gated SPECT imaging in asymptomatic diabetic patients: clinical decision and optimal therapeutic approach

    Article • Cardiologia Croatica, May 2013, Medical Publishing, d.o.o.

    Professor marija B Vavlukis

  128. Poster Session 1: Thursday 8 December 2011, 08:30-12:30 * Location: Poster Area

    Article • European Journal of Echocardiography, November 2011, European Society of Cardiology

    Professor marija B Vavlukis

  129. Abstracts

    Article • European Heart Journal Supplements, April 2011, Oxford University Press (OUP)

    Professor Alexander E Berezin, Professor marija B Vavlukis

  130. Occurrence and Progression of Coronary Artery Disease in Patients with Type 2 Diabetes

    Article • Open Access Macedonian Journal of Medical Sciences, December 2008, Macedonian Journal of Medical Science

    Professor marija B Vavlukis

  131. ESTIMATION OF METABOLIC SYNDROME' COMPONENTS IN TYPE 2 DIABETIC POPULATION WITH CORONARY ARTERY DISEASE – A COMPARISON OF TWO CRITERIA

    Article • Atherosclerosis Supplements, May 2008, Elsevier

    Professor marija B Vavlukis

  132. Functional outcome and quality of life after coronary artery bypass surgery in patients with severe heart failure and hibernated myocardium

    Article • Nuclear Medicine Communications, March 2008, Wolters Kluwer Health

    Professor marija B Vavlukis

  133. ENDOTHELIAL DYSFUNCTION CORRELATES WITH PLASMA FIBRINOGEN AND HDL CHOLESTEROL IN TYPE 2 DIABETIC PATIENTS WITH CORONARY ARTERY DISEASE

    Article • Journal of Thrombosis and Haemostasis, July 2007, Wiley

    Professor marija B Vavlukis

  134. 6.29Diagnostic value of transient ischaemic dilation (TID) and increased lung uptake as markers of severe and extensive myocardial ischaemia

    Article • Journal of Nuclear Cardiology, March 2007, Springer Science + Business Media

    Professor marija B Vavlukis

  135. 1.18Combined low level treadmill-dipyridamol versus dipyridamol stress protocol in patients undergoing SPECT MPI

    Article • Journal of Nuclear Cardiology, March 2007, Springer Science + Business Media

    Professor marija B Vavlukis

  136. 8.1Influence of hibernated myocardium on left ventricular remodelling in patients with severe ischaemic heart failure and coronary artery bypass surgery

    Article • Journal of Nuclear Cardiology, March 2007, Springer Science + Business Media

    Professor marija B Vavlukis

  137. 6.20hs-CRP values in patients with normal myocardial perfusion

    Article • Journal of Nuclear Cardiology, March 2007, Springer Science + Business Media

    Professor marija B Vavlukis

  138. Mo-P4:253 Relationship between extend of myocardial viability and post-revascularization improvement of left ventricular ejection fraction

    Article • Atherosclerosis Supplements, January 2006, Elsevier

    Professor marija B Vavlukis

  139. Prognosis and risk stratification of diabetic patients after coronary stenting: Impact of silent ischemia on cardiovascular events

    Article • Journal of Nuclear Cardiology, March 2005, Springer Science + Business Media

    Professor marija B Vavlukis

  140. Is there a relationship between myocardial perfusion scintigraphy and carotid ultrasound findings in predictive model for coronary artery bypass patients?

    Article • Journal of Nuclear Cardiology, March 2005, Springer Science + Business Media

    Professor marija B Vavlukis

  141. The influence of combined therapy with perindopril and trimetazidine on the silent myocardial ischemia and on left ventricular remodeling in essential hypertension

    Article • Journal of Nuclear Cardiology, March 2005, Elsevier

    Professor marija B Vavlukis

  142. 40th EASD Annual Meeting of the European Association for the Study of Diabetes

    Article • Diabetologia, August 2004, Springer Science + Business Media

    Dr. Mykola D. Khalangot, Professor Alexandra Kautzky-Willer, George R. Cowgill Professor of Medicine and Physiology Gerald I Shulman, Professor marija B Vavlukis

  143. 377 Impact of anemia and cachexia upon mortality in chronic heart failure

    Article • European Journal of Heart Failure Supplements, June 2004, Oxford University Press (OUP)

    Professor marija B Vavlukis

  144. M.521 Implication of body mass index on long-term prognosis in patients after coronary artery bypass surgery

    Article • Atherosclerosis Supplements, April 2004, Elsevier

    Professor marija B Vavlukis

  145. Compact reversal rotationally shearing interferometer

    Article • November 2003, SPIE

    Professor marija B Vavlukis

  146. 1864 Assessment of myocardial perfusion after coronary stenting and implications of incomplete revascularization in multivessel coronary disease: role of gated single-photon emission computed tomography imaging

    Article • European Heart Journal, March 2003, Elsevier

    Professor marija B Vavlukis

  147. Left ventricular perfusion/function differences between ischemic and dilated cardiomyopathy assessed by SPECT myocardial imaging: visual and quantitative computer analysis

    Article • January 2002, Springer Science + Business Media

    Professor marija B Vavlukis

  148. 1.25 Dipyridamole myoscintigraphy in patients with left bundle branch block

    Article • Journal of Nuclear Cardiology, January 2001, Springer Science + Business Media

    Professor marija B Vavlukis

  149. 7.58 Myocardial viability: nitrate enhanced gated SPECT MIBI Tc99m an adequate alternation for Tl201 rest-redistribution protocol

    Article • Journal of Nuclear Cardiology, January 2001, Springer Science + Business Media

    Professor marija B Vavlukis

  150. 1.38 Significance of ST-segment changes detected by ambulatory electrocardiographic monitoring and exercise treadmill stress testing in female patients who underwent myocardial perfusion scintigraphy

    Article • Journal of Nuclear Cardiology, January 2001, Springer Science + Business Media

    Professor marija B Vavlukis

  151. 16.10 Evaluation of diagnostic and prognostic markers of myocardial perfusion scintigraphy and exercise treadmill stress test in patients with multivessel coronary artery disease

    Article • Journal of Nuclear Cardiology, January 2001, Springer Science + Business Media

    Professor marija B Vavlukis

  152. Myocardial perfusion scintigraphic findings in patients with ischaemic cardyomiopathy versus those with preserved left ventricular function

    Article • European Journal of Heart Failure, June 2000, Wiley

    Professor marija B Vavlukis

  153. Bisoprolol reduces episodes of ventricular tachycardia and sudden cardiac death in subjects with chronic heart failure

    Article • European Journal of Heart Failure, June 2000, Wiley

    Professor marija B Vavlukis